United Therapeutics (UTHR) Easily Tops Q4 EPS Expectations
Tweet Send to a Friend
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $2.88, $1.37 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
